Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F5 | P12259 | 1/20 | 0.39 |
| ▸ | KCNQ3 | O43525 | 5/20 | 0.37 |
| ▸ | KCNQ2 | O43526 | 5/20 | 0.37 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.34 |
| ▸ | KCNQ1 | P51787 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13748337 | 0.92 | F10 (0.39) | F10F2F5KCNQ3KCNQ2 | |
| SCHEMBL12101125 | 0.91 | F10 (0.38) | F10F2F5KCNQ3KCNQ2 | |
| SCHEMBL12101123 | 0.88 | F10 (0.37) | F10F2F5 | |
| SCHEMBL4267977 | 0.88 | F10 (0.37) | F10F2F5 | |
| SCHEMBL13394451 | 0.87 | KCNQ3 (0.35) | F10F2F5KCNQ3KCNQ2 | |
| Hydrochloric Acid SCHEMBL4268185 | 0.86 | KCNQ3 (0.34) | F10F2F5KCNQ3KCNQ2 | |
| SCHEMBL1503968 | 0.86 | RAB9A (0.39) | F10 | |
| SCHEMBL1503972 | 0.86 | RAB9A (0.39) | F10 | |
| SCHEMBL1504130 | 0.84 | F10 (0.54) | F10F2F5 | |
| SCHEMBL6891023 | 0.84 | F10 (0.38) | F10F2F5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7342014-B2 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20050020645-A1 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020645-A1 | Diamine derivatives | C9, C1S, C1R | F10 196/4885F2 4/4885F5 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.